Skip to the open sheet
Before the planA peptide care workbook

Read. Ask. Leave room for an answer.

Questions before a care plan

Make the evidence answer the claim being made.

Ask for the source behind a treatment claim. Then check whether it concerns the same medicine, the same form, and the same intended use.

Keep the claim and its source together. A paper title by itself does not explain what a clinic is offering. Ask the clinician to walk through the connection in ordinary words.

What does each kind of record tell you?

Approval information as of September 26, 2026.

A facility entered in FDA (the Food and Drug Administration) records is described as registered; that entry is called registration. In the medicine list, NDC stands for National Drug Code: the product’s listing number. Neither record proves FDA approval of a medicine.

The FDA says its published problem reports do not prove that a medicine caused the reported event.

Those reports cannot tell you how often a medicine causes harm.

A warning letter is a dated warning.

An FDA warning letter tells a business what the agency believes it has done wrong. The letter is not a final finding. Later replies and discussions can change the position described.

A business without a published letter may simply not have been reviewed.

Ask what is still unknown. A useful answer can have limits. Keep those limits beside the claimed benefit when comparing the proposal.

Trace a claim

Notes for this chapter